Adaptimmune Therapeutics (ADAP) IPO Opens Up 13%
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Adaptimmune Therapeutics (ADAP) Prices 11.25M IPO at $17/ADS
May 6, 2015 10:05 AM EDTAdaptimmune Therapeutics plc (Nasdaq: ADAP) announced the pricing of its initial public offering of 11,250,000 American Depositary Shares (ADSs) at a price to the public of $17.00 per ADS. In addition, the underwriters have been granted a 30-day option to purchase up to an additional... More



